Clinical Next-Generation Sequencing Reveals Divergent Mutational Patterns in BRAF V600, BRAF Non-V600, and NRAS Mutations in Advanced Melanoma

被引：0
|
作者：
Siroy, A. E. [1 ]
Prieto, V. G. [1 ]
Gershenwald, J. E. [1 ]
Woodman, S. E. [1 ]
Roszik, J. [1 ]
Aldape, K. D. [1 ]
Luthra, R. [1 ]
Patel, K. P. [1 ]
Rmitbort, M. J. [1 ]
Davies, M. A. [1 ]
Lazar, A. J. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
MODERN PATHOLOGY | 2014年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
573
引用
收藏
页码：143A / 143A
页数：1
相关论文
共 50 条
  • [31] Detection of BRAF V600 Mutations in Metastatic Melanoma Comparison of the Cobas 4800 and Sanger Sequencing Assays
    Qu, Kevin
    Pan, Qiulu
    Zhang, Xi
    Rodriguez, Luis
    Zhang, Ke
    Li, Hairong
    Ho, Albert
    Sanders, Heather
    Sferruzza, Anthony
    Cheng, Shih-Min
    Nguyen, Diedre
    Jones, Dan
    Waldman, Frederic
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 790 - 795
  • [32] Targeted Therapy for Melanomas Without BRAF V600 Mutations
    Christian Menzer
    Jessica C. Hassel
    Current Treatment Options in Oncology, 2022, 23 : 831 - 842
  • [33] Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
    Hyman, David M.
    Puzanov, Igor
    Subbiah, Vivek
    Faris, Jason E.
    Chau, Ian
    Blay, Jean-Yves
    Wolf, Juergen
    Raje, Noopur S.
    Diamond, Eli L.
    Hollebecque, Antoine
    Gervais, Radj
    Elena Elez-Fernandez, Maria
    Italiano, Antoine
    Hofheinz, Ralf-Dieter
    Hidalgo, Manuel
    Chan, Emily
    Schuler, Martin
    Lasserre, Susan Frances
    Makrutzki, Martina
    Sirzen, Florin
    Veronese, Maria Luisa
    Tabernero, Josep
    Baselga, Jose
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (08): : 726 - 736
  • [34] Targeted Therapy for Melanomas Without BRAF V600 Mutations
    Menzer, Christian
    Hassel, Jessica C.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (06) : 831 - 842
  • [35] Concomitant Non-V600E BRAF and KRAS Mutations in Colorectal Carcinoma by Next-Generation Sequencing: A Distinct Subtype
    Srivastava, Pallavi
    Mishra, Sridhar
    Shukla, Saumya
    Sharma, Pooja
    Husain, Nuzhat
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2024, 32 (06) : 1186 - 1190
  • [36] Clinical characteristics of patients with non-V600 BRAF mutant melanomas.
    Kim, Dae Won
    Nowroozi, Sasan
    Kim, Kunhwa
    Davies, Michael A.
    Routbort, Mark
    Lazar, Alexander J. F.
    Frankian, Silva
    Siroy, Alan
    Bedikian, Agop Y.
    Papadopoulos, Nicholas E.
    Hwu, Wen-Jen
    Hwu, Patrick
    Woodman, Scott
    Patel, Sapna Pradyuman
    Kim, Kevin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [37] Detection of BRAF V600K Mutations in Melanoma: A Comparison of Cobas 4800 BRAF V600 Mutation Test and Laboratory Developed Pyrosequencing Assay
    Wenceslao, S. M.
    Gale, J.
    Vasef, M. A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 700 - 701
  • [38] Vemurafenib in Patients Harboring V600 and Non V600 BRAF Mutations: Final Results of the NSCLC Cohort from the AcSe Trial
    Mazieres, J.
    Montane, L.
    Barlesi, F.
    Coudert, B.
    Souquet, P. J.
    Otto, J.
    Gervais, R.
    Moro-Sibilot, D.
    Monnet, I.
    Brain, E.
    Huillard, O.
    Quere, G.
    Debieuvre, D.
    Fabre, E.
    Jaffro, M.
    Collot, S.
    Ferretti, G.
    Tiffon, C.
    Oukhatar, C. Mahier-Ait
    Blay, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S348 - S349
  • [39] VEMURAFENIB FOR BRAF V600 MUTATED ADVANCED MELANOMA: RESULTS OF TREATMENT BEYOND PROGRESSION
    Haanen, J. B. A. G.
    Scholtens, A.
    Geukes, M.
    van Thienen, H.
    van Tinteren, H.
    ANNALS OF ONCOLOGY, 2014, 25
  • [40] The potential for BRAF V600 inhibitors in advanced cutaneous melanoma: rationale and latest evidence
    Lemech, Charlotte
    Infante, Jeffrey
    Arkenau, Hendrik-Tobias
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2012, 4 (02) : 61 - 73
12345